SiNAPTIC Technologies has received a grant from the Colorado Office of Economic Development and International Trade (OEDIT) Advanced Industries Accelerator program. The grant will support the development and testing of SiNAPTIC’s printable silicon nitride slurry for submission to the FDA.
Colorado company SiNAPTIC operates two divisions: SiNAPTIC Technologies focuses on R&D, prototyping, and OEM manufacturing, while SiNAPTIC Surgical aims to become an FDA-registered medical device producer. The grant will enable biocompatibility testing and process validation, essential steps toward FDA Master File submission.
“SiNAPTIC Technologies is passionate about serial production and contract manufacturing of technical ceramics to help customers overcome product design issues associated with traditional ceramic manufacturing,” said SiNAPTIC’s CEO, Bryan Scheer, MD.
“Upon the completion of this grant-funded project, we will attract innovators wanting to license our silicon nitride slurry to develop their own medical products for the regulatory benefits offered by the Master File.”
The Advanced Industries Accelerator program supports businesses commercializing new technologies in Colorado, promoting growth and job creation in advanced industries. SiNAPTIC Technologies’ advancements in ceramic additive manufacturing are expected to improve customer access to medical and industrial applications.
SiNAPTIC’s Grant Coordinator, Kevin Altman, expressed pride in their efforts being recognized and supported, emphasizing the potential impact of their printable silicon nitride on the domestic industry.
SiNAPTIC Technologies’ grant will fund silicon nitride slurry testing and team expansion, advancing ceramic additive manufacturing for medical and industrial applications.